Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Cilo Cybin Holdings Limited is an international enterprise focused on the cultivation, production, and distribution of medicinal cannabis products. Its extensive catalog includes bottled THC and CBD oils, cannabis flowers, and vaping solutions. The company further supplies tinctures, edibles, topical applications, capsules, and specialized devices. Additionally, they manufacture a variety of advanced cannabis extracts, such as full and broad-spectrum refined crude oil, CBD and THC distillates, and pure isolates of CBD, CBG, CBN, and THC. Beyond its product offerings, Cilo Cybin provides essential support services to the cannabis industry, encompassing packaging, storage, and export facilitation. Consumers can directly acquire these goods through its dedicated online retail channel, known as the Brand Shop. Founded in 2018, the firm maintains its base of operations in Centurion, South Africa.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is overpriced on P/FCF.